Yasi Deng

Nanomedicines targeting activated immune cells and effector cells for rheumatoid arthritis treatment.

Huang-he Yu, Feibing Huang, Bin Li, 2024, Journal of controlled release : official journal of the Controlled Release Society.

Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets

Huang-he Yu, Yong Yang, Wei Wang, 2024, Molecular medicine.